 |
|
|
Epilepsy Pipeline Conference: Webcasts & Abstracts
MORNING SESSION
Welcome & Overview
Warren Lammert |
Garry Menzel, PhD |
Keynote Lecture: Psychiatric Applications Of Anticonvulsant Medications
John Krystal, MD
Professor and Deputy Chairman, Department of Psychiatry
Yale University School of Medicine
New Haven, CT
View Abstract 
(PDF) Session Webcast 
The Use of Animal Models for the Early Identification and Characterization of Anticonvulsant Efficacy
H. Steven White, PhD
Director, Anticonvulsant Drug Development Program
Professor, Department of Pharmacology and Toxicology
Anticonvulsant Drug Development Program
University of Utah
Salt Lake City, Utah
View Abstract (PDF) Session Webcast
Evolutionary Treatments: New approaches to known mechanisms
Jacqueline French, MD
Vice President, Research and Co-Chair, Scientific Advisory Board, Epilepsy Therapy Project
Director, Epilepsy Study Consortium
Professor of Neurology, NYU Comprehensive Epilepsy Center
New York University
New York, NY
View Abstract (PDF) Session Webcast Thanks to Meir Bialer, PhD
Revolutionary Treatments: New CNS Drug Targets and Breakthrough Epilepsy Treatment Strategies
Michael Rogawski, MD, PhD
Professor and Chair
Department of Neurology
School of Medicine
University of California, Davis
Sacramento, CA
View Abstract (PDF) Session Slides
New Technology Platforms: New Formulations and Delivery Systems
C. James Cloyd, PharmD
Professor and Weaver Endowed Chair
Director, Center for Orphan Drug Research
University of Minnesota
Minneapolis, MN
View Abstract (PDF) Session Webcast
Devices: Brain stimulators, implants
Steven Schachter, MD
Vice President, Medical Information, Epilepsy Therapy Project
Professor of Neurology and Director of Research
Department of Neurology
Harvard Medical School and Beth Israel Deaconess Medical Center
Boston, MA
View Abstract (PDF) Session Webcast
MIDDAY PIPELINE UPDATE REVIEW
The NeuroPace RNS™ System: Responsive Cortical Stimulation for Epilepsy
Martha Morrell, MD
Chief Medical Officer
NeuroPace
Mountain View, CA
View Abstract (PDF)
Session Webcast
The NeuroVista Seizure Advisory System
John Harris
President and CEO
NeuroVista Corporation
Seattle, WA
View Abstract (PDF)
Session Webcast
Drug Delivery
Daniel Abrams, MD
Sierra Neuropharmaceuticals, Inc.
Department of Pyschiatry
University of Colorado Health Sciences Center
Denver, CO
View Abstract (PDF)
Session Webcast
Subtype selective T-type calcium channel blockers as a novel antiepileptic therapy
Elizabeth Tringham, PhD
Neuromed Pharmaceuticals
Vancouver, BC, Canada
Presentations Not Available
Subtype selective T-type calcium channel blockers as a novel antiepileptic therapy
Gregory C. Rigdon, PhD
Vice President, New Product Development
Icagen, Inc.
Durham, NC
View Abstract (PDF)
Session Webcast
NMDA blocker AV-101
H.Ralph Snodgrass, PhD
President, CEO and Director
VistaGen Therapeutics, Inc.
South San Francisco, CA
View Abstract (PDF)
Session Webcast
Dynamin Inhibitors - Drug Discovery and Development Candidates for Epilepsy
Jens Tampe, PhD
Business Development Manager
Bio-Link
Melbourne, Victoria, Australia
View Abstract (PDF)
Session Webcast
2DG: A Glucose Analogue With Novel Anticonvulsant And Antiepileptic Actions
Thomas Sutula, MD, PhD
Chief Technical Officer, NeuroGenomeX, Inc.
Detling Professor and Chair, Department of Neurology
Director, Center for Neuroscience
University of Wisconsin
Madison, WI
Presentations Not Available
NPY gene transfer
Christine V. Sapan, PhD
Chief Development Officer
Executive Vice President
Neurologix, Inc.
Fort Lee, NJ
Presentations Not Available
Development of AAV-Galanin for Temporal Lobe Epilepsy
R. Jude Samulski, PhD
Founder & CEO
ASKLEPIOS BioPharmaceutical Inc
Chapel Hill, NC
View Abstract (PDF)
Session Webcast
GANAXOLONE - Neuroactive Steroid Therapy For Epilepsy
Elizabeth Garofalo, MD
Interim Medical Officer
Marinus Pharmaceuticals, Inc.
Branford, CT
View Abstract (PDF)
Session Webcast
Clobazam/vigabatrin/IV carbamazepine
Steven Collins, MD, PhD
Chief Scientific Officer and V.P. of Clinical Affairs
Ovation Pharmaceuticals
Deerfield, IL
View Abstract (PDF)
Session Webcast
ZP-4 and Intranasal clonazepam: JZP-8, Jazz Pharmaceuticals
Jouku Isojarvi, MD
Jazz Pharmaceuticals
Palo Alto, CA
Development of Novel Systematically-Active Neuropeptides for the Treatment of Epilepsy and Pain
H. Steven White, PhD
Director, Anticonvulsant Drug Development Program
Professor, Department of Pharmacology and Toxicology
Anticonvulsant Drug Development Program
University of Utah
Salt Lake City, Utah
AFTERNOON SESSION
Epilepsy & CNS Market Dynamics: The Value of Proposition in Epilepsy and Beyond
Panelists:
| David Barrow (moderator) Vice President L.E.K. Consulting, LLC Boston, MA |
Heath Lukatch, PhD Partner, Novo Ventures (US) Inc. San Francisco, CA |
| Anand Mehra, MD Principal Sofinnova Ventures San Francisco, CA |
Roger Quy, PhD General Partner Technology Partners Palo Alto, CA |
| Gregory Went, PhD CEO and Chairman Adamas Pharmaceuticals, Inc. Emeryville, CA |
View Topics (PDF)
Session Webcast
Shared Mechanisms, Broader Opportunities, Development Paths in Epilepsy, Pain, Anxiety: Lessons Learned and Applied in the Clinical Development of Epilepsy and CNS Treatments
Panelists:
| Frank Fischer (moderator) President and CEO NeuroPace, Inc. Mountain View , CA |
Matthew Simonian UCB Inc. Smyrna, GA 30080 |
| Brian Klein, PhD CNS Drug Discovery J&J Pharmacuetical Research and Development Spring House, PA |
John Krystal MD Professor and Deputy Chairman, Department of Psychiatry Yale University School of Medicine New Haven, CT |
| Manuel Lopez-Figueroa PhD Vice President Bay City Capital San Francisco, CA |
View Topics (PDF) Session Webcast
Regulatory Issues: How to Manage the FDA Process
Panelists:
| Elizabeth Garofalo, MD (moderator) Interim Medical Officer Marinus Pharmaceuticals, Inc. Branford, CT |
Henry Mansbach, MD Senior Vice President, Global Drug Development Valeant Pharmaceuticals Aliso, Viejo, CA |
| Kenneth Sommerville, MD Vice President, Neuropathics Schwarz Biosciences, Inc. A Member of UCB Group Raleigh, NC |
Reese Terry Founder Cyberonics, Inc. Houston, TX |
| Mark Versavel, MD Executive Medical Director Sepracor Marlborough, MA |
View Topics (PDF)
Session Webcast
An Opinionated Examination of the Epilepsy Pipeline
Panelists:
| Orrin Devinsky (moderator) Co-Founder, Vice President, Development and Co-Chair Scientific Advisory Board, Epilepsy Therapy Project Professor of Neurology, Neurosurgery and Psychiatry, NYU Epilepsy Center New York University New York, NY |
Steven Collins, MD, PhD Chief Scientific Officer and V.P. of Clinical Affairs Ovation Pharmaceuticals Deerfield, IL |
| Jacqueline French, MD Vice President, Research and Co-Chair, Scientific Advisory Board, Epilepsy Therapy Project Director, Epilepsy Study Consortium Professor of Neurology, NYU Comprehensive Epilepsy Center New York University New York, NY |
Ka Lum Director, New Product Planning Jazz Pharmaceuticals Palo Alto, CA |
| Roger Porter, MD Consultant Devon, PA |
Daniel O'Connell Managing Partner NeuroVentures Capital, LLC Charlottesville, CA |
| Nancy Santili VP Commercial Strategy and Portfolio Planning Endo Pharmaceuticals Chadds Ford, PA |
View Topics (PDF)
Session Webcast
Business Model for Partnering With Investors, Industry and Entrepreneurs
Joyce Cramer (ETP President)
President, Epilepsy Therapy Project
Associate Research Scientist, Yale University School of Medicine
ETP Regional Office: Orange, CT
View Abstract (PDF)
Session Webcast
Epilepsy & CNS Therapeutic Development - Everyone Can Benefit
Warren Lammert |
Garry Menzel, PhD |